INVO Bioscience
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$4.16M N/A	$822.19K -80.23%	$3.02M 267.37%	Avg: $28.61M Low: $28.61M High: $28.61M avg. 847.26%	Avg: $45.32M Low: $45.32M High: $45.32M avg. 58.39%	Avg: $65.59M Low: $65.59M High: $65.59M avg. 44.73%
Net Income % change YoY	$-6.65M N/A	$-10.89M -63.67%	$-8.03M 26.23%	Avg: $-260K Low: $-313.19K High: $-313.19K avg. 96.76%	Avg: $5.79M Low: $5.95M High: $5.95M avg. 2330.38%	Avg: $767.31K Low: $767.31K High: $767.31K avg. -86.76%
EBITDA % change YoY	$-5.37M N/A	$-10.82M -101.45%	$-6.88M 36.45%	Avg: $-28.61M Low: $-28.61M High: $-28.61M avg. -315.88%	Avg: $-45.32M Low: $-45.32M High: $-45.32M avg. -58.39%	Avg: $-65.59M Low: $-65.59M High: $-65.59M avg. -44.73%
EPS % change YoY	-$12.52 N/A	-$17.97 -43.53%	-$5.13 71.45%	Avg: -$0.2 Low: -$0.2 High: -$0.2 avg. 96.10%	Avg: $3.8 Low: $3.8 High: $3.8 avg. 2000%	Avg: $0.49 Low: $0.49 High: $0.49 avg. -87.10%
Operating Expenses % change YoY	$9.23M N/A	$11.11M 20.42%	$7.85M -29.35%	Avg: $145.73M Low: $145.73M High: $145.73M avg. 1755.66%	Avg: $230.82M Low: $230.82M High: $230.82M avg. 58.39%	Avg: $334.09M Low: $334.09M High: $334.09M avg. 44.73%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 780.12% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -313.19K, average is -260K and high is -313.19K.

Wall Street analysts forecast annual average revenue growth of 316.79% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $28.61M, average is $28.61M and high is $28.61M.

Wall Street analysts forecast annual average earnings growth of 669.66% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.2, average is -$0.2 and high is $-0.2.